Glycostem is an innovator in allogeneic cellular immunotherapy using Natural Killer (NK) cells for treatment of leukemia, lymphoma and solid tumors.
Find out more
Check out the team that is operating at the cutting edge of immunotherapy
We are at an exciting time with lots of news; check it out
The ability to make cancer a chronic disease
oNKord® is our lead candidate but we are working on more products
Our mould-breaking and loyal supporters
We share all our articles to promote international cooperation
If you subscribe you agree to the Privacy Notice of Glycostem Therapeutics B.V. as found on the website.